Activated TGF-β/BMP signaling has been demonstrated to contribute to the onset and progression of CCMs in patients and mouse models (Maddaluno et al., 2013; Bravi et al., 2016; Cuttano et al., 2016). The gene discussed is TGFB1; the disease is cerebrocostomandibular syndrome.